Ketamine Infusion Associated with Improved Neurology in a Patient with NMDA Receptor Encephalitis
Author(s) -
Michael MacMahon,
M R Naysmith,
Stephanie McCallion,
Jonathan Rhodes
Publication year - 2013
Publication title -
case reports in critical care
Language(s) - English
Resource type - Journals
eISSN - 2090-6439
pISSN - 2090-6420
DOI - 10.1155/2013/383125
Subject(s) - ketamine , medicine , plasmapheresis , anti nmda receptor encephalitis , context (archaeology) , neurology , dyskinesia , anesthesia , dystonia , nmda receptor , encephalitis , intensive care , intensive care medicine , psychiatry , receptor , disease , antibody , paleontology , parkinson's disease , immunology , biology , virus , virology
A young lady was ventilated on intensive care for a prolonged period with NMDA receptor encephalitis. She had undergone steroid, immunoglobulin, and plasmapheresis with no evidence of recovery. Her main management issue was the control of severe orofacial and limb dyskinesia. Large doses of sedating agents had been used to control the dystonia but were ineffective, unless she was fully anaesthetised. The introduction of a ketamine infusion was associated with a dramatic improvement in her symptoms such that it was possible to remove her tracheostomy two days after commencement. She was discharged shortly after that and is making a good recovery. The successful use of ketamine has not previously been described in this context, and we hope this case report will provide some insight into the management of this rare but serious condition.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom